GreyMatter Capital

GreyMatter Capital is a venture capital firm dedicated to supporting bold founders building the future of mental health and emotional wellness. The firm believes that innovative approaches to mental well-being have the power to reshape healthcare and improve various aspects of life, including work, learning, and interpersonal relationships. With decades of experience in investing, building, and advising companies at the intersection of mental health and technology, GreyMatter Capital is committed to fostering significant advancements in this field. The team is supported by a network of advisors, including successful behavioral health company founders, world-class clinicians, researchers, technologists, policy advocates, and healthcare executives. Through this community, they help founders identify promising areas of research and technological opportunity, provide access to playbooks and data to shape their strategy, support critical hires, assist in closing deals with customers, and offer specialized guidance and capital along the way. The firm's portfolio includes companies like Kyan Health, which raised $16.7 million to upgrade workplace wellness with AI-powered preventative care. GreyMatter Capital operates with a focus on impact investing, aiming to improve learning outcomes and future readiness for students aged 6-22 years in India and Southeast Asia. Their portfolio in this sector includes companies like Buddy4Study, ConveGenius, IMAX Program, and Shirsa Labs. The firm invests across various stages, including Pre-Seed, Seed, Series A, Series B, Growth, Late Stage, and Pre-IPO, and focuses on sectors such as Digital Health, Wellness, and Fitness. The team comprises experienced professionals, including Danish Munir, Founding Partner; Anna Wang, Vice President; Andrew Barr, Founding Partner; and Natalie Bartlett, Venture Partner. The firm's headquarters are located in San Francisco, California, United States.